Anavo Therapeutics is a biotechnology company focused on the development of allosteric modulators for phosphatases, aiming to create a pipeline of novel therapeutics for various diseases.

Bioqube Ventures is a specialist life sciences investment firm. We source, finance and develop innovative therapeutic assets and technologies. We put our venture creation experience at work to translate and de-risk scientific innovation, advancing our investment portfolio and maximising value for investors.

Bioqube Ventures launched in 2020 its first independent fund “Bioqube Factory Fund I”.

… An early stage venture capital fund – dedicated to advancing exciting science in vibrant European ecosystems to breakthrough therapies for patients.

… A fit-for-purpose dual investment model – besides more classical investments in first investment rounds, we will have special attention for so called “Create” projects that require additional de-risking prior to creating new ventures. 

… A hands-on approach – the team is a mix of fund managers, sector experts and serial entrepreneurs that have a proven track record in successfully leading companies on their growth paths.

Bioqube Ventures

Fellowship opportunity! Do you have a scientific background, are you passionate about developing therapeutics and eager to learn more about what makes venture capital tick in biotech? Then this 6-month Fellowship program at Bioqube might be the right fit for you! Find out more in the description below ⤵️ #vc #biotech #fellowship

Exciting update from our portfolio company @Bicara Therapeutics at @ESMO !

Welcome Krishna Polu ! What a great addition to our Bioqube Ventures team! Proud to be part of this family!

Exciting update from Bioqube portfolio company Bicara Therapeutics, congratulations to the team on unveiling their manuscript. Read all about it below. #aacr23 #BFFI
https://lnkd.in/eMAwSuya

Bioqube Ventures is pleased to welcome Bicara Therapeutics to our portfolio, a clinical-stage biotech advancing its lead program BCA101 and its pipeline of investigational candidates to treat solid tumor cancers.

https://lnkd.in/efJAtW9Q

COM:BIOQUBEVENTURES

Anavo Therapeutics

Analysis Not Available